{{Rsnum
|rsid=34059508
|Gene=SLC22A1
|Chromosome=6
|position=160154805
|Orientation=plus
|GMAF=0.008264
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=SLC22A1
}}{{PharmGKB
|RSID=rs34059508
|Name_s=SLC22A1: G465R
|Gene_s=SLC22A1
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19940846
|Annotation=Reduced metformin and MPP+ uptake in transfected cells
|Drugs=metformin; MPP+
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111559
}}

{{PharmGKB
|RSID=rs34059508
|Name_s=SLC22A1:1393G>A (G465R)
|Gene_s=SLC22A1
|Feature=Exon/NonSyn
|Evidence=PubMed ID:17609683
|Annotation=SNP contributes to variation in the pharmacokinetics of metformin.
|Drugs=metformin
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA162356080
}}

{{GET Evidence
|gene=SLC22A1
|aa_change=Gly465Arg
|aa_change_short=G465R
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs34059508
|overall_frequency_n=208
|overall_frequency_d=10758
|overall_frequency=0.0193344
|n_genomes=1
|n_genomes_annotated=0
|n_haplomes=1
|n_articles=2
|n_articles_annotated=2
|in_pharmgkb=Y
|pph2_score=0.99
|nblosum100=6
|autoscore=4
|webscore=N
|n_web_uneval=10
}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}